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Abstract
Introduction Broad-range rDNA PCR provides an alternative,
cultivation-independent approach for identifying bacterial DNA
in reactive and other form of arthritis. The aim of this study was
to use broad-range rDNA PCR targeting the 16S rRNA gene in
patients with reactive and other forms of arthritis and to screen
for the presence of DNA from any given bacterial species in
synovial fluid (SF) samples.
Methods We examined the SF samples from a total of 27
patients consisting of patients with reactive arthritis (ReA) (n =
5), undifferentiated arthritis (UA) (n = 9), rheumatoid arthritis (n
= 7), and osteoarthritis (n = 6) of which the latter two were used
as controls. Using broad-range bacterial PCR amplifying a 1400
bp fragment from the 16S rRNA gene, we identified and
sequenced at least 24 clones from each SF sample. To identify
the corresponding bacteria, DNA sequences were compared to
the EMBL (European Molecular Biology Laboratory) database.
Results Bacterial DNA was identified in 20 of the 27 SF
samples (74, 10%). Analysis of a large number of sequences
revealed the presence of DNA from more than one single
bacterial species in the SF of all patients studied. The nearly
complete sequences of the 1400 bp were obtained for most of
the detected species. DNA of bacterial species including
Shigella  species,  Escherichia  species, and other coli-form
bacteria as well as opportunistic pathogens such as
Stenotrophomonas maltophilia and  Achromobacter
xylosoxidans  were shared in all arthritis patients. Among
pathogens described to trigger ReA, DNA from Shigella sonnei
was found in ReA and UA patients. We also detected DNA from
rarely occurring human pathogens such as Aranicola species
and Pantoea ananatis. We also found DNA from bacteria so far
not described in human infections such as Bacillus niacini,
Paenibacillus humicus, Diaphorobacter species and uncultured
bacterium genera incertae sedis OP10.
Conclusions Broad-range PCR followed by cloning and
sequencing the entire 16S rDNA, allowed the identification of
the bacterial DNA environment in the SF samples of arthritic
patients. We found a wide spectrum of bacteria including those
known to be involved in ReA and others not previously
associated with arthritis.
OA: osteoarthritis; PCR: polymerase chain reaction; RA: rheumatoid arthritis; ReA: reactive arthritis; SF: synovial fluid; ST: synovial tissue; UA: undif-
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Introduction
The actual pathogenic event initiating arthritis is largely
unknown. For several forms of arthritis, an infectious etiology
has been postulated [1-3]. In particular, reactive arthritis (ReA)
is known to be triggered by a variety of bacteria. For Salmo-
nella, Yersinia, and Chlamydia, a persistent infection has been
hypothesized due to the intraarticular presence of bacterial
antigens, DNA, and/or RNA [4-6]. There is also evidence that
undifferentiated arthritis is a form of ReA ('forme fruste') possi-
bly due to a preceding but asymptomatic infection [7,8]. PCR
using universal 16S rRNA primers is a highly sensitive tool
allowing detection of unknown, that is unsuspected, patho-
gens relating to all eubacterial species [9-11]. This tool has
been used before in patients with ReA, undifferentiated arthri-
tis (UA), and other arthropathies. However, in most studies,
the PCR products were of sufficient length to determine the
genus of the bacteria in the synovial samples, but were not
long enough to identify the species level [12-14].
We previously used the broad-range PCR, cloning and
sequencing the entire 16S rDNA and demonstrated the pres-
ence of a large number of bacterial DNA in the synovial tissue
(ST) of patients with ReA, UA, and other arthropathies [15].
These bacterial DNA were mainly derived from commensals
that are normally present in the skin and gut. We also detected
DNA of specific bacterial groups that have not been detected
in arthritis samples or in human infections so far, suggesting
that these new bacteria possibly could have a pathogenic rel-
evance, particularly with regard to the ST. The detection of
such a variety of bacterial groups after cloning and near full-
length 16S rDNA sequencing obtained in ST samples has
raised the question if the identical bacterial DNA communities
could reside in both the ST and the synovial fluid (SF) of
matched arthritis patients [15]. In addition, the composition of
bacterial DNA from ST samples has not been compared com-
prehensively with that of matched SF samples in arthritis
patients. Besides, a detailed analysis of SF bacterial DNA and
their comparison with those from corresponding ST samples
might help to determine whether intraarticular bacterial DNA
might change over time between the two synovial compart-
ments.
As opposed to SF [12,16], the bacterial DNA communities in
the ST are well documented [13,14,17-19] and to our knowl-
edge, there is no study that has amplified the entire 16S rDNA
from SF samples.
Accordingly, we now continue our study using PCR as well as
cloning and sequencing of the entire 16S rDNA to identify any
bacterial DNA potentially present in the SF samples of patients
with ReA, UA, and other forms of arthritis who were also ana-
lyzed previously [15].
Materials and methods
Patients and synovial fluid samples
Twenty-seven patients with active arthritis and knee effusion
gave informed consent and were included in the study, which
was approved by the local ethical committees. ST samples of
these patients were used in a previous study [15]. The clinical
characteristics as well as technical aspects regarding preven-
tion of contamination during sampling have recently been pub-
lished in detail [15].
Among the 27 patients included in the study, five were diag-
nosed with ReA, and nine with undifferentiated arthritis (UA);
we also included seven patients with rheumatoid arthritis (RA)
and six with osteoarthritis (OA) who served as controls. In the
current study, the 27 patients were identical to the 27 patients
analyzed in our previously published study (from patient 2 to
patient 28) [15]. The clinical features and demographic char-
acteristics of the patients are summarized in Table 1. SF sam-
ples were aspirated by standard needle puncture, snap frozen
in liquid nitrogen, and stored at -80°C until analysis.
Automated DNA extraction from synovial fluid and 
broad-range PCR amplification of 16S rRNA genes, 
cloning and sequencing of bacterial DNA
For 10 minutes, 500 μl of SF were centrifuged at 10,000 g.
The whole SF cell pellet was subjected to DNA extraction
using the MagNA Pure system (Roche Molecular Biochemi-
cals, Meylan, France). Prior to the MagNA Pure extraction, 500
μl of lysis buffer (200 mM sodium chloride, 20 mM Tris hydro-
chloric acid, pH 8, 50 mM ethylenediaminetetraacetic acid
and 1% SDS) and 25 μl of proteinase K (10 mg/ml) (Sigma,
St Louis, MO, USA) were added to the SF cell pellet.
Bacterial 16S rDNA fragments were amplified from SF
extracted DNA by broad-range PCR amplification using uni-
versal bacterial 16S rRNA gene-specific oligonucleotide prim-
ers Bac08 and Uni1390, as previously described [15].
Products of the expected size (approximately 1400 bp) were
inserted into a vector using a cloning kit (pGEM-T vector;
Promega, Madison, WI, USA). Sequencing and 16S rDNA
analysis were performed as previously described [15].
Data analysis
Statistical analysis was performed using SPSS 11.0 software
(SPSS; Chicago, IL, USA). A P < 0.05 was considered statis-
tically significant.
Results
PCR positivity by the broad-range PCR amplification 
system
PCR was positive in 20 of the 27 (74.10%) patients indicating
the presence of bacterial 16S rDNA within the synovial sam-
ples. Of note, PCR was positive in five out of five (100%)
patients with ReA and also in nine out of nine (100%) patients
with UA. In the control group, bacterial 16S rDNA was ampli-Available online http://arthritis-research.com/content/11/4/R102
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fied in three out of seven (43%) RA patients and in three of six
(50%) OA patients. Accordingly, the presence of bacterial
DNA within the SF samples was significantly higher in ReA
and UA patients as compared with RA and OA patients (14
out of 14 (100%) vs 6 of 13 (46.2%); P = 0.006).
At least 24 individual clones were selected from each PCR
product and sequenced. A summary of the total number of
sequences analyzed in each patient is depicted in Table 2.
Only full-length (1300 to 1400 bp) sequences of high quality
were analyzed in detail. Most bacterial sequences had at least
97% sequence similarity with any known cultivated or uncul-
tured bacteria. The percentage of similarity to the best fit
sequence in the database, the accession number, and the
sequence length of each probe are listed in Table 3.
Bacterial 16S rDNA sequences identified in synovial fluid 
samples
Each patient's SF samples contained a diverse range of bac-
terial DNA-related species (Table 2). The majority of patho-
gens across all groups were identified as Shigella species and
Stenotrophomonas maltophilia. DNA from a total of 69 various
individual bacterial species were detected in SF samples from
ReA and UA patients, whereas only 10 different bacterial DNA
were found in SF samples from RA and OA patients. In addi-
tion, DNA from 20 bacterial species was detected in both the
study and the control groups.
In ReA and UA patients, apart from Shigella sonnei DNA,
there was no other DNA-derived bacteria so far described to
trigger ReA. There were sequences from commensal bacteria,
in particular those from the skin or the intestinal tract (Propion-
ibacterium acnes, Escherichia coli, and other coliform bacte-
ria). We also detected additional species previously assigned
to the Pseudomonas genus such as DNA of Pseudomonas
poae,  Delftia acidovorans, and Burkholderia cepacia. A
detailed sequence analysis of the PCR-positive samples of
ReA and UA patients revealed a number of DNA of bacteria
that have previously been described in human infections but
not in arthritis, including Rhizobium radiobacter,  Pantoea
ananatis, and Capnocytophaga sputigena. Except for P. anan-
atis, these DNA sequences were observed in only one individ-
ual (Table 3)
DNA products from environmental bacteria previously
detected in arthritis, such as Achromobacter xylosoxidans,
Alcaligenes faecalis, and Flavobacterium mizutaii were com-
monly found in both the study and control groups. DNA of Ara-
nicola species bacterium rarely described in humans but not
associated with arthritis was common in patients with ReA,
UA, and RA and was detected in more than one case (Table
3).
Some clones fell into environmental species not previously
reported in human infections including DNA of Paenibacillus
humicus, Bacillus niacini, and Diaphorobacter species, and
other bacteria, which have not yet been cultured (Table 3).
DNA from the candidate division OP10 bacterium was
detected in SF samples of only two patients with UA. These
Table 1
Demographic and clinical features of the study patients
Diagnosis (patients; n = 27) Median disease duration, 
months (range)
Actual age or median age, 
years (range)
Sex ratio (M/F) Clinical details
ReA (n = 5) 2.4 (1 to 6) 32.4 (20 to 50) 4:1
1 22 M Sexually acquired ReA; Ct IgG 
positivea, Ct IgA positive 
serologyb
2 40 F Sexually acquired ReA;
3 20 M Sexually acquired ReA; Ct IgG 
positive serologya; Ct IgA 
positive serologyb; B27+d
4 50 M Sexually acquired ReA; Ct IgA 
positive serologyb; Ct positive 
PCRc; B27+d
5 30 M Sexually acquired ReA
UA (n = 9) 25 (2 to 60) 40 (22 to 59) 5:4 -
RA (n = 7) 66 (12 to 228) 44 (39 to 53) 2:5 -
OA (n = 6) 14 (12 to 24) 58 (44 to 70) 5:1 -
a Serology was determined for Ct-IgG antibodies by Micro Immunofluorescence assay as described by Wang and Grayston [29]. bSerology was 
determined for Ct-IgA antibodies by ELISA (Labsystems, Hilsinki, Finland). cChlamydia PCR in genital swabs was determined by Cobas Amplicor 
PCR assay (Roche Diagnostics Molecular Systems, Inc, CA, USA). dHLA-B27 positivity was determined using a microcytotoxicity assay.
Ct = Chlamydia trachomatis; RA = rheumatoid arthritis; ReA = reactive arthritis; OA = osteoarthritis; UA = undifferentiated arthritis.Arthritis Research & Therapy    Vol 11 No 4    Siala et al.
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Table 2
Details of bacterial species-derived DNA sequences identified in each patient*
Patient Total number of bacterial DNA sequences DNA sequences identified in each patient
ReA
14 5 10 × Stenotrophomonas maltophilia, 7 × Shigella species, 6 × Propionibacterium acnes, 3 
× Ralstonia species, 3 × Shigella sonnei, 3 × uncultured bacterium, 2 × Bradyrhizobium 
elkanii, 1 × uncultured γ proteobacterium, 1 × uncultured γ proteobacterium, 2 × uncultured 
Sphingobacterium species, 1 × Aranicola species, 1 × Agrobacterium species, 1 × 
Burkholderia species, 1 × Escherichia coli, 1 × Paenibacillus humicus, 1 × Pantoea 
ananatis, 1 × uncultured β proteobacterium.
24 7 1 3  ×  Stenotrophomonas maltophilia, 4× Shigella species, 3 × Aranicola species, 3 × 
Ralstonia species, 2 × β proteobacterium, 2 × γ proteobacterium, 2 × uncultured β 
proteobacterium, 1 × Agrobacterium species,, 1 × Bacteroidetes bacterium, 1 × 
Escherichia coli, 1 × Escherichia species, 1 × Flavobacterium mizutaii, 1 × Pantoea 
ananatis, 1 × Paenibacillus humicus, 1 × Paenibacillus species, 1 × Propionibacterium 
acnes, 3 × Shigella sonnei 1 × Streptococcus mitis, 1 × swine manure bacterium, 1 × 
uncultured α proteobacterium, 1 × uncultured Bacteroidetes bacterium, 1 × uncultured 
Flavobacterium species, 1 × uncultured soil bacterium.
34 2 1 0  ×  Shigella species, 9 × Stenotrophomonas maltophilia, 3 × Aranicola species, 3 × 
uncultured bacterium,, 2 × Escherichia species, 2 × Paenibacillus humicus, 2 × 
Streptococcus mitis, 1 × Achromobacter xylosoxidans, 1 × Bradyrhizobium elkanii, 1 × 
Bacteroidetes bacterium, 1 × Flavobacterium mizutaii, 1 × γ proteobacterium, 1 × 
Propionibacterium acnes, 1 × Shigella sonnei, 1 × Streptococcus mitis, 1 × uncultured 
Flavobacterium species, 1 × uncultured Methylococcaceae bacterium, 1 × uncultured 
Bacteroidetes bacterium
44 9 11 × Stenotrophomonas maltophilia, 6 × γ proteobacterium, 5 × Shigella species, 5 × 
Shigella sonnei, 3 × Aranicola species, 3 × Comamonas testosteroni, 3 × uncultured 
bacterium, 2 × Escherichia species, 2× Propionibacterium acnes, 2 × uncultured 
Flavobacterium species, 2 × uncultured β proteobacterium, 1 × Alcaligenes faecalis, 1 × 
Flavobacterium mizutaii, 1 × Paenibacillus humicus 1 × Pelomonas saccharophila, 1 × 
Pseudomonas species.
53 1 5  ×  Escherichia coli, 4 × Stenotrophomonas maltophilia, 3 × Escherichia coli, 2 × 
Pseudomonas species, 2 × Shigella species, 2 × Sphingomonas faeni, 1 × Alcaligenes 
faecalis, 1 × β proteobacterium, 1 × Comamonas testosteroni, 1 × Diaphorobacter 
species, 1 × Delftia acidovorans, 1 ×Flavobacterium mizutaii, 1 × γ proteobacterium, 1 × 
uncultured bacterium, 1 × uncultured β proteobacterium, 1 × Pantoea ananatis, 1 × 
Propionibacterium acnes, 1 × Ralstonia species, 1 × Shigella sonnei,
UA
64 7 1 3  ×  Stenotrophomonas maltophilia, 9 × Shigella species, 7 × γ proteobacterium, 2 × 
uncultured bacterium, 2 × uncultured Veillonella species, 1 × Alcaligenes faecalis, 1× 
Agrobacterium species, 1 × Escherichia species, 1 × Streptococcus thermophilus, 1 × 
Flavobacterium mizutaii, 1 × Propionibacterium acnes, 1 × uncultured β proteobacterium, 
1 × uncultured bacterium, 1 × uncultured candidate division OP10 bacterium, 1 × Pantoea 
ananatis, 1 × Shigella sonnei, 1 × unidentiefied bacterium, 1 × uncultured Flavobacterium 
species, 1 × uncultured Sphingobacterium species.
73 0 8  ×  Stenotrophomonas maltophilia, 3 × Shigella species, 2 × Comamonas testosteroni, 2 
× Paenibacillus humicus, 2 × Ralstonia species, 2 × uncultured bacterium, 2 × uncultured 
β proteobacterium, 2 × uncultured Flavobacterium species, 1 × Burkholderia species, 1 × 
Bradyrhizobium elkanii, 1 × Bacteroidetes bacterium, 1 × Escherichia coli, 1 × 
Flavobacterium mizutaii, 1 × γ proteobacterium, 1 × Shigella sonnei
84 3 15 × Stenotrophomonas maltophilia, 5 × Shigella species, 3 × Escherichia species, 3 × 
Paenibacillus humicus, 2 × uncultured bacterium, 2 × uncultured β proteobacterium, 1 × 
Alcaligenes faecalis, 1 × Aranicola species, 1 × Bradyrhizobium elkanii, 1 × 
Flavobacterium mizutaii, 1 × γ proteobacterium, 1 × Ralstonia species, 1 × Staphylococcus 
pasteuri, 1 × Streptococcus mitis, 1 × Streptococcus pneumoniae, 1 × Streptococcus 
species, 1 × uncultured candidate division OP10 bacterium, 1 × uncultured Streptococcus 
species, 1 × uncultured Veillonella species.
93 8 1 1  ×  Aquabacterium commune, 8 × Shigella species, 3 × Aranicola species, 3 × 
Paenibacillus humicus, 2 × Alcaligenes faecalis, 2 uncultured bacterium, 1 × β 
proteobacterium, 1 × Comamonas testosteroni, 1× Escherichia species, 1 × Kocuria 
species, 1 × Pseudomonas species, 1 × Paracoccus species, 1 × Streptococcus 
thermophilus, 1 × Streptococcus species, 1 × uncultured β proteobacteriumAvailable online http://arthritis-research.com/content/11/4/R102
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bacterial DNA sequences have not been previously character-
ized by rDNA sequencing because they exhibit less than 97%
similarity to known database sequences. We could find no
clear association between the presence of a particular bacte-
rial DNA and clinical symptoms.
Discussion
In the present study we used broad-range PCR amplification,
cloning, and sequencing of the full-length 16S rDNA from a
wide variety of bacterial species in the SF samples of all
patients studied. Only a few studies have been conducted to
detect and identify the bacterial DNA communities in SF sam-
ples of patients with ReA, UA, and others arthropathies. In
these studies, only short fragments of DNA were amplified
10 41 13 × Stenotrophomonas maltophilia, 4 × Shigella species, 3 × γ proteobacterium, 3 × 
Shigella sonnei, 1 × Aranicola species, 1 × Alcaligenes faecalis, 1× Aeromonas species, 
1× Burkholderia species, 1 × Bradyrhizobium elkanii, 1 × Comamonas testosteroni, 1 × 
Capnocytophaga sputigena 1 × Enterococcus faecium, 1× Escherichia species, 1 × 
Enterobacter hormaechei, 1 × Pseudomonas poae, 1 × Pantoea ananatis, 1 × 
Paenibacillus humicus, 1 × Rhodococcus species, 1 × Ralstonia species, 1 uncultured 
bacterium, 1 × uncultured γ proteobacterium, 1 × uncultured Flavobacterium species.
11 36 6 × Stenotrophomonas maltophilia, 5 × Shigella species, 4 × γ proteobacterium, 4 × 
Ralstonia species, 3 × Escherichia coli, 2 × Bradyrhizobium elkanii, 2 × Comamonas 
testosteroni, 2 × uncultured bacterium, 1 × Achromobacter xylosoxidans, 1 × Alcaligenes 
faecalis, 1 × Bacteroidetes bacterium, 1 × Flavobacterium mizutaii, 1 × Rhizobium 
radiobacter, 1 × Rhodococcus species, 1 × uncultured β proteobacterium, 1 × uncultured 
organism.
12 22 4 × Shigella species, 4 × Stenotrophomonas maltophilia, 3 × Alcaligenes faecalis, 2 × 
Shigella sonnei, 2 × uncultured β proteobacterium, 2 × uncultured bacterium, 1 × 
Aminobacter aminovorans, 1 × Achromobacter xylosoxidans, 1 × Paenibacillus humicus, 1 
× Ralstonia species, 1 × uncultured organism.
13 37 12 × Stenotrophomonas maltophilia, 3 × Shigella species, 3 × uncultured bacterium, 2 × 
Bacillus niacini, 2 × Ralstonia species, 1 × β proteobacterium, 1 × Bradyrhizobium 
japonicum, 1 × Burkholderia cepacia, 1 × Corynebacterium durum, 1 × Comamonas 
testosteroni, 1 × Flavobacterium mizutaii, 1 × γ proteobacterium, 1 × uncultured β 
proteobacterium, 1 × uncultured Sphingobacterium species, 1 × Mycobacterium 
aubagnense, 1 × Shigella sonnei., 1 × Sphingomonas species, 1 × Sphingomonas 
species, 1 × Pseudomonas poae, 1 × Pantoea ananatis.
14 36 10 × Stenotrophomonas maltophilia, 7 × Ralstonia species, 3 × Comamonas testosteroni, 
3 × uncultured bacterium, 2 × γ proteobacterium, 1 × Escherichia species, 1 × 
Flavobacterium mizutaii, 1 × Methylomicrobium species, 1 × Paenibacillus humicus, 1 × 
Pantoea ananatis, 1 × Photorhabdus luminescens, 1 × Streptococcus pneumoniae, 1 × 
uncultured Sphingobacterium species, 1 × uncultured Flavobacterium species, 1 × 
uncultured β proteobacterium, 1 × uncultured Firmicutes bacterium.
RA
15 24 10 × Stenotrophomonas maltophilia, 3 × uncultured Flavobacterium species, 2 × 
Comamonas testosteroni, 2 × uncultured bacterium, 1 × Aranicola species, 1 × 
Flavobacterium mizutaii, 1 × Paenibacillus humicus, 1 × Shigella species, 1 × 
Staphylococcus cohnii, 1 × Sphingobacterium thalpophilum, 1 × uncultured 
Sphingobacterium species.
16 13 5 × uncultured β proteobacterium, 4 × uncultured Flavobacterium species, 2 × uncultured 
Sphingobacterium species, 1 × Comamonas testosterone, 1 × uncultured bacterium.
17 8 3 × Escherichia species, 2 × uncultured bacterium, 1 × Alcaligenes faecalis, 1 × 
Comamonas testosteroni, 1 × Shigella species.
OA
18 18 4 × Stenotrophomonas maltophilia, 4 × Shigella species, 2 × Flavobacterium mizutaii, 2 × 
uncultured Flavobacterium species, 2 × uncultured Sphingobacterium species, 1 × 
Acinetobacter junii, 1 × Escherichia coli O157, 2 × uncultured bacterium.
19 16 5 × Stenotrophomonas maltophilia, 3 × Shigella species, 3 × uncultured bacterium, 1 × 
Alcaligenes faecalis, 1 × Comamonas testosteroni, 1 × Flavobacterium mizutaii, 1 × 
Paenibacillus humicus, 1 × Ralstonia species.
20 17 4 × Stenotrophomonas maltophilia, 3 × Shigella species, 3 × uncultured bacterium, 1 × 
Achromobacter xylosoxidans, 1 × Alcaligenes faecalis, 1 × Bacillus cereus, 1 × 
Escherichia species, 1 × Rothia mucilaginosa, 2 × uncultured β proteobacterium
OA = osteoarthritis; RA = rheumatoid arthritis; ReA = reactive arthritis; UA = undifferentiated arthritis.
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Details of bacterial species-derived DNA sequences identified in each patient*Arthritis Research & Therapy    Vol 11 No 4    Siala et al.
Page 6 of 11
(page number not for citation purposes)
Table 3
Bacterial species identified by sequencing of cloned 16S rDNA
Bacterium-derived DNA identified in 
SF samples
Number of patients in whom bacterial 
DNAs were detected
Accession numbera Length of the sequenceb % Similarityc
Bacteria identified in ReA and UA patients (n = 69)
Bacteria previously detected in arthritis
Aeromonas species (1 UA) [EMBL:AF099027] 1400 97.77
Burkholderia species (1 ReA + 1 UA) [EMBL:AY769903] 1391 99.13
Burkholderia species (1 UA) [EMBL:AY134849] 1388 99.71
Burkholderia cepacia (1 UA) [EMBL:AY946010] 1390 99.89
Escherichia coli (1 ReA) [EMBL:CP000243] 1400 99.14
Escherichia coli (2 ReA) [EMBL:U00096] 1400 100.00
Escherichia coli (1 ReA + 2 UA) [EMBL:V00348] 1400 99.50
Methylomicrobium species (1 UA) [EMBL:AF194538] 1380 98.83
Propionibacterium acnes (5 ReA + 1 UA) [EMBL:AB108477] 1386 99.05
Pseudomonas species (1 ReA) [EMBL:DQ213044] 1386 99.06
Pseudomonas species (1 ReA) [EMBL:AY014811] 1395 99.06
Pseudomonas species (1 UA) [EMBL:AM409368] 1396 99.21
Paracoccus species (1 UA) [EMBL:AY745834] 1320 98.92
Rhodococcus species (2 UA) [EMBL:AF420412] 1374 97.29
Shigella sonnei (5 ReA + 5 UA) [EMBL:CP000038] 1400 99.71
Shigella sonnei (1 UA) [EMBL:X96964] 1389 99.78
Sphingomonas species (1 UA) [EMBL:AB110635] 1341 99.85
Sphingomonas species (1 UA) [EMBL:AF385529] 1341 100.00
Streptococcus species (1 UA) [EMBL:AF316593] 1400 98.55
Streptococcus species (1 UA) [EMBL:AF385523] 1400 99.28
Streptococcus mitis (1 ReA) [EMBL:AJ295848] 1400 97.92
Streptococcus mitis (1 ReA) [EMBL:AJ617805] 1322 98.71
Streptococcus mitis (1 ReA) [EMBL:AF003929] 1396 99.36
Streptococcus mitis (1 ReA + 1 UA) [EMBL:AY518677] 1404 99.86
Streptococcus pneumoniae (2 UA) [EMBL:AM157442] 1400 98.64
Streptococcus thermophilus (2 UA) [EMBL:AY188354] 1397 99.57
Bacteria not previously detected in arthritis but detected in human infection
Agrobacterium species (2 ReA + 1 UA) [EMBL:AY775177] 1344 99.40
Bradyrhizobium elkanii (2 ReA + 4 UA) [EMBL:AY904749] 1347 99.40
Capnocytophaga sputigena (1 UA) [EMBL:AF133536] 1378 98.96
Corynebacterium durum (1 UA) [EMBL:AF537593] 1391 99.58
Delftia acidovorans (1 ReA) [EMBL:AB020186] 1309 97.63
Enterococcus faecium (1 UA) [EMBL:EF533988] 1396 99.42
Enterobacter hormaechei (1 UA) [EMBL:AY995561] 1400 99.70
Kocuria species (1 UA) [EMBL:AY864652] 1387 99.85
Mycobacterium aubagnense (1 UA) [EMBL:AY859683] 1372 99.27Available online http://arthritis-research.com/content/11/4/R102
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Pantoea ananatis (3 ReA + 4 UA) [EMBL:DQ133546] 1400 98.80
Photorhabdus luminescens (1 UA) [EMBL:AY444555] 1333 99.85
Pseudomonas poae (2 UA) [EMBL:AJ492829] 1386 98.99
Rhizobium radiobacter (1 UA) [EMBL:AJ389902] 1300 99.67
Staphylococcus pasteuri (1 UA) [EMBL:AJ717376] 1411 99.86
Bacteria not previously detected in humans
Aquabacterium commune (1 UA) [EMBL:AF035054] 1416 99.70
Aminobacter aminovorans (1 UA) [EMBL:AJ011759] 1344 98.72
Bacillus niacini (1 UA) [EMBL:AB021194] 1400 99.14
Bradyrhizobium japonicum (1 UA) [EMBL:AB072418] 1200 97.81
Diaphorobacter species (1 ReA) [EMBL:DQ294626] 1387 99.78
Pelomonas saccharophila (1 ReA) [EMBL:AB021407] 1381 99.42
Paenibacillus species (1 ReA) [EMBL:AM162345] 1385 99.35
Sphingomonas faeni (1 ReA) [EMBL:AJ429239] 1340 97.82
Uncultured bacteria
Bacteroidetes bacterium (2 UA + 1 ReA) [EMBL:AY395022] 1394 96.11*
Bacteroidetes bacterium (1 ReA) [EMBL:DQ195837] 1300 98.39
β Proteobacterium (2 ReA + 2 UA) [EMBL:AY162033] 1396 99.57
γ Proteobacterium (4 ReA + 6 UA) [EMBL:AY162042] 1399 99.00
γ Proteobacterium (1 ReA + 4 UA) [EMBL:AY162068] 1400 99.50
swine manure bacterium (1 ReA) [EMBL:AY167969 ] 1395 99.21
Uncultured α proteobacterium (1 ReA) [EMBL:AF445680] 1342 97.00
Uncultured Bacteroidetes bacterium (2 ReA) [EMBL:AY921801] 1384 97.04
Uncultured bacterium (2 UA) [EMBL:AY958813] 1388 99.88
Uncultured β proteobacterium (1 ReA + 1 UA) [EMBL:AF445700] 1372 99.78
Uncultured β proteobacterium (1 UA) [EMBL:DQ316806] 1391 97.46
Uncultured candidate division OP10 
bacterium
(2 UA) [EMBL:AF418946] 1362 90.29*
Uncultured Firmicutes bacterium (1 UA) [EMBL:EF071401] 1400 99.57
Uncultured γ Proteobacterium (1 UA) [EMBL:AF324537] 1396 99.96
Uncultured γ Proteobacterium (1 ReA) [EMBL:AJ318146] 1400 97.63
Uncultured γ Proteobacterium (1 ReA) [EMBL:AY770720] 1393 96.91*
Uncultured Methylococcaceae 
bacterium
(1 ReA) [EMBL:EF019533] 1398 97.55
Uncultured organism (2 UA) [EMBL:DQ395839] 1392 99.85
Uncultured soil bacterium (1 ReA) [EMBL:DQ297948] 1340 99.85
Uncultured Streptococcus species (1 UA) [EMBL:AY256519] 1400 99.21
Uncultured Veillonella species (2 UA) [EMBL:AM157449] 1400 99.37
Bacteria identified in control group (RA and OA patients; n = 10)
Bacteria previously detected in arthritis (in joint)
Acinetobacter junii (1 OA) [EMBL:AB101444] 1387 99.28
Bacillus cereus (1 OA) [EMBL:AB247137] 1399 98.36
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Rothia mucilaginosa (1 OA) [EMBL:DQ409140] 1375 98.69
Staphylococcus cohnii (1 RA) [EMBL:AJ717378] 1399 99.57
Bacteria not previously detected in arthritis but detected in human infection
Escherichia coli O157 (1 OA) [EMBL:AE005174] 1394 97.56
Bacteria not previously detected in humans
Sphingobacterium thalpophilum (1 RA) [EMBL:AJ43817] 1388 94.02*
Uncultured bacteria
Uncultured bacterium (1 OA) [EMBL:DQ800655] 1394 97.99
Uncultured bacterium (1 RA) [EMBL:AY958855] 1388 99.78
Uncultured bacterium (1 RA) [EMBL:AY958896] 1380 99.57
Uncultured bacterium (1 RA + 1 OA) [EMBL:DQ818800] 1398 99.57
Common bacteriad (n = 20)
Bacteria previously detected in arthritis
Achromobacter xylosoxidans (1 ReA + 2 UA+ 1 OA) [EMBL:AF439314] 1389 99.50
Alcaligenes faecalis (2 ReA + 6 UA + 2 OA + 1 RA) [EMBL:AY548384] 1395 99.70
Comamonas testosterone (1 ReA + 4 UA +1 OA + 3 RA) [EMBL:AB007996] 1390 99.35
Comamonas testosterone (2 ReA + 3 UA + 1 OA) [EMBL:M11224] 1390 98.05
Escherichia species (3 ReA + 5 UA + 1 OA + 1 RA) [EMBL:DQ337503] 1400 99.86
Flavobacterium mizutaii (4 ReA + 6 UA + 2 OA + 1 RA) [EMBL:AJ438175] 1385 94.00*
Shigella species (5 ReA + 8 UA + 3 OA + 2 RA) [EMBL:DQ337523] 1399 99.70
Stenotrophomonas maltophilia (5 ReA + 8 UA + 3 OA + 1 RA) [EMBL:AJ293470] 1396 99.75
Stenotrophomonas maltophilia (5 ReA + 8 UA + 3 OA + 1 RA) [EMBL:AB294557] 1396 99.86
Bacteria not previously detected in arthritis but detected in human infection
Aranicola species (4 ReA + 3 UA + 1 RA) [EMBL:AM398227] 1400 99.64
Ralstonia species (3 ReA + 7 UA + 1 OA) [EMBL:AB045276] 1387 99.86
Bacteria not previously detected in humans
Paenibacillus humicus (4 ReA + 6 UA +1 OA + 1 RA) [EMBL:AM411528] 1399 98.60
Uncultured bacteria
Uncultured bacterium (4 ReA + 4 UA + 1 OA) [EMBL:DQ818781] 1394 98.90
Uncultured bacterium (5 ReA + 4 UA + 2 OA + 2 RA) [EMBL:AY838480] 1389 94.00*
Uncultured bacterium (2 ReA + 3 UA + 1 OA + 2 RA) [EMBL:AB076874] 1389 94.00*
Uncultured bacterium (1 ReA +1 OA) [EMBL:AY838458] 1382 99.64
Uncultured bacterium (1 UA + 1 OA) [EMBL:DQ824599] 1398 99.57
Uncultured β proteobacterium (4 ReA + 6 UA + 1 OA + 1 RA) [EMBL:DQ366010] 1384 99.71
Uncultured Flavobacterium species (3 ReA + 5 UA + 1 OA + 2 RA) [EMBL:DQ366085] 1300 97.20
Uncultured Sphingobacterium 
species
(1 ReA + 3 UA + 1 OA + 2 RA) [EMBL:AB076874] 1389 94.16*
Number in brackets after species names indicate the number of patient set from whom bacteria were detected. aAccession number of the 
bacterial species in the EMBL database. bLength of alignment on which the 16S rDNA inserted sequence and the corresponding sequence in the 
database are similar. cIn the '% similarity' column, asterisks indicate highlight instances where the % similarity is below 97%. dThe 'Common 
bacteria' row shows the bacteria identified in ReA, UA, RA, and OA patients.
Bacterial species detected only in SF samples and not in ST samples from our previous study [15], are indicated in bold.
OA = osteoarthritis; RA = rheumatoid arthritis; ReA = reactive arthritis; SF = synovial fluid; UA = undifferentiated arthritis.
Table 3 (Continued)
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allowing solely the determination of the bacterial genus but not
the identification of the species level. This is, to our knowl-
edge, the first study using the full-length 16S rRNA gene as a
target for broad-spectrum PCR to detect bacterial DNA in SF
samples allowing the identification of the species level.
Sequence analysis of the PCR-positive samples revealed the
presence of a wide spectrum of bacterial DNA in SF samples
of all studied patients. False positivity due to contamination
poses a problem when broad-range PCR targeting the 16S
rRNA is used [20-22]. However, our recently published study
outlines extensive measures, which were also taken in the
present study in order to avoid any contamination [15]. From a
practical point of view, it is important to notice that we did not
surgically incise the skin at the site of the aspiration thus avoid-
ing contamination by the skin flora but our results are rather
similar to those obtained by others who took this precaution
[14]. PCR and extraction controls consistently yielded nega-
tive results indicating that the PCR products detected in pos-
itive samples are most likely derived from the bacterial rRNA
genes actually present in SF cells. In addition, the sequences
obtained varied between patients and DNA from several
organisms has also been identified in arthritic human joints in
independent laboratories [12-14,17,18], suggesting that their
presence is unlikely to be a consequence of contamination.
The most common sequences of species found in SF samples
of all patients (e.g. A. xylosoxidans, A. faecalis, F. mizutaii, and
S. maltophilia) were also seen in the previous study [15],
except the DNA from Aranicola  species implying that they
might be opportunistic colonizers of inflamed joints. S. mal-
tophilia DNA was identified most frequently. This organism is
an opportunistic pathogen and has previously been detected
in arthritic knee joints [12,15,17]. Of note, other bacterial DNA
have been described in human infections but not so far in
arthritis were identified in the SF samples of our arthritic
patients. Some of them are detected only in SF samples but
not in their matched ST samples, such as R. radiobacter and
Pantoae ananatis. Recently, we reported that DNA derived
from uncultured bacteria and from environmental organisms
that have not been previously detected in human samples
could also be demonstrated in ST samples [15]. Similarly, in
SF samples such bacterial DNA was detected including Ami-
nobacter aminovorans, B. niacini, Diaphorobacter species,
and uncultured candidate division OP10 bacterium. Several
studies have also detected unsuspected uncultured and/or
cultured bacteria not considered as human pathogens in
arthritic joints but they were found by sequencing short DNA
fragments [12-14,16]. Thus, the identification of such bacte-
rial species after cloning and near-full length 16S DNA
sequencing might be of interest and should be pursued. How-
ever, their presence in the joint can not provide definite evi-
dence of their replication or a functional role in arthritis.
Our results also confirmed the presence of E. coli sequences
in SF samples as previously found in ST samples of arthritis
patients [15]. This could indicate the ability of E. coli DNA to
colonize inflamed joints; the gut in different patients would be
expected to contain a material derived from a range of E. coli
'subspecies' [23-25].
Our analysis of SF samples and their matched ST samples
confirmed a wide spectrum of bacterial DNA-related species
detected in each individual patient. Accordingly, a significant
correlation was found between the diversity of bacterial spe-
cies detected in SF and matched ST at the patient level (r =
0.522, P = 0.018). However, they revealed a different profile
in regard to their known potential of triggering ReA in either SF
or ST samples. Thus, the Shigella flexneri sequences were not
detected in any of the SF samples whereas S. sonnei 16 rDNA
sequences were detected more frequently in SF samples of
five ReA and five UA patients as compared with the ST sam-
ples of one ReA and one UA patient [15]. DNA of Shigella
species was also prevalent in SF samples as demonstrated
previously in ST samples [15], but it was more frequently
detected in SF samples (five ReA, eight UA, two RA, and three
OA in SF vs two ReA, four UA, two RA, and one OA in ST sam-
ples). Although S. sonnei and Shigella species were detected
more frequently in SF than in ST samples, the difference was
statistically not significant.
We detected DNA from Shigella  species in our cohort of
patients with various forms of arthritis and S. sonnei, known to
trigger ReA, only in ReA and UA samples. Shigella DNA posi-
tive patients had no clinical signs of previous intestinal infec-
tion with an enteric organism. These patients may have been
asymptomatic, or the preceding gastrointestinal symptoms
may have been mild and overlooked by the patients [3]. It is
possible that enteric organisms may migrate from asympto-
matic primary sites of the infection to the synovial compart-
ment [3]. Most Shigella ReA caused by S. sonnei are sporadic
cases [26]. The most recent published case of S. sonnei
related ReA was attributed to sexual transmission of the path-
ogen [27]. In our study, we detected S. sonnei DNA in five
ReA patients presenting with an urogenital infection, which is
consistent with the possibility that this species could be
related to sexual transmission.
A composition of a mixture of bacterial nucleic acids was com-
mon in our cohort of patients with various forms of arthritis, as
has been described in previous studies [13-15,17,18]. The
bacterial DNA might be incorporated by macrophages, which
are disseminated by the circulation and reach the joint due to
an increased cellular recruitment. As opposed to a single
organism, such mixtures may increase the risk of triggering an
immune response finally culminating in synovitis. However,
genetic susceptibility factors of the host are also playing an
important role particularly in persistent infections [10,28]. As
mixtures of bacterial nucleic acids are also detectable in theArthritis Research & Therapy    Vol 11 No 4    Siala et al.
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SF samples from patients with RA and OA, we cannot exclude
that this may represent a normal 'background' phenomenon
not necessarily causing synovitis [10,17]. Another limitation of
our study lies in the fact that we could not detect Chlamydia
trachomatis DNA or other common bacteria known to trigger
posturethritic arthritis.
Conclusions
Our study provides a valuable overall picture of the bacterial
DNA environment present in the SF of the actively inflamed
joints of arthritis patients. Characterization of the DNA reveals
a wide spectrum of organisms so far not known to be present
in human infections, not known to be present in inflamed joints
of arthritis patients, and not known to trigger ReA. There is also
a differential bacterial colonisation and/or infection of SF and
ST samples because the analysis of SF can identify a number
of bacterial DNA-related species, which have not been
detected in ST samples as studied earlier [15] and has helped
to confirm that the composition of bacterial DNA may change
over time in joint cavity.
Accordingly, the analysis of SF or ST samples from different
arthropathies patients by broad-range PCR is essentially
capable of characterising the bacterial DNA environment
present in joint cavity. As synovial biopsy is a difficult act, SF
is well practical for such purpose.
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